U.S. FDA qualifies first AI tool to help speed liver disease drug development

The cloud-based system, called AIM-NASH, analyzes images of liver tissue to help doctors assess signs of diseases such as fat buildup, inflammation, and scarringThe cloud-based system, called AIM-NASH, analyzes images of liver tissue to help doctors assess signs of diseases such as fat buildup, inflammation, and scarring https://www.thehindu.com/sci-tech/technology/us-fda-qualifies-first-ai-tool-to-help-speed-liver-disease-drug-development/article70374820.ece 2025-12-09T04:15:49.000Z Technology {}